ADA 2018 ออกใหม่ มีหลายหัวข้อเปลี่ยนไป ดังนี้
- The recommendation for testing for prediabetes and type 2 diabetes in children and adolescents was changed, suggesting testing for youth who are overweight or obese and have one or more additional risk factors
- Pancreatitis was added to the section on comorbidities, including a new recommendation about the consideration of islet autotransplantation to prevent postsurgical diabetes in patients with medically refractory chronic pancreatitis who require total pancreatectomy.
- New recommendations for antihyperglycemic therapy for adults with type 2 diabetes have been added to reflect recent cardiovascular outcomes trial (CVOT) data, indicating that people with atherosclerotic cardiovascular disease (ASCVD) should begin with lifestyle management and metformin and subsequently incorporate an agent proven to reduce major adverse cardiovascular events and/or cardiovascular mortality after considering drug-specific and patient factors.
- Comprehensive Medical Evaluation and Assessment of Comorbidities ตามรูปแนบ
- อ่านต่อ ดังลิงค์ด้านล่าง